Poland· PL-100449464
Diptivil
A vildagliptin product containing vildagliptinum, registered in Poland by MSN Labs Europe Limited. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Vildagliptin is registered in 16 of 19 countries.
Countries holding a registration under ATC A10BH02 (vildagliptin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Vildagliptin · ATC A10BH02
16 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of vildagliptin costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.32 in France to $1.98 in Switzerland — a ×6.2 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vildagliptin · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.98
- IT Italy$1.0
- FR France$0.32
The record
At a glance
URPL (Poland)- Active substance
- Vildagliptinum
- Manufacturer
- MSN Labs Europe Limited
- Country
- Poland (PL)
- ATC code
- A10BH02
- ATC class
- Vildagliptin
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 11
2 priced- gtin0590999172968456 szt.PLN 29.79
- gtin0590999172972128 szt.PLN 15.76
- gtin05909991563493
- gtin05909991563509
- gtin05909991563516
- gtin05909991729660
- gtin05909991729677
- gtin05909991729691
- gtin05909991729707
- gtin05909991729714
- gtin05909991563523
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vildagliptin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALIKVALEgis Pharmaceuticals PLC, Budapešť
- SpainGALVUS 50 mg COMPRIMIDOSNovartis Europharm Limited
- United KingdomGalvus 50mg tabletsWaymade Healthcare Plc
- FranceGALVUS 50 mg, compriméNOVARTIS EUROPHARM (IRLANDE)
- ItalyGALVUSNOVARTIS EUROPHARM LTD
- SwedenDalmevin 50 mg TablettMedochemie Ltd
- NetherlandsGalvus 50 mg tabletten, tablettenNovartis Europharm Limited
- FinlandGalvusNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Melkart, Saxotin
- Belgium · Vildagliptin Krka
- Bulgaria · Глипвило, Далмевин
- Cyprus · Aglimon, Dalmevin
- Czechia · Alikval, Anvildis
- Germany · Vildabetes, Vildagliptin Al
- Denmark · Vildagliptin "a. E. Tiefenbacher", Vildagliptin "axunio"
- Estonia · Dalmevin, Glypvilo
- Spain · Vildagliptina, Vildagliptina Alter
- Finland · Vildagliptin Krka, Vildagliptin Ratiopharm
- France · Vildagliptine Accord, Vildagliptine Arrow
- United Kingdom (Northern Ireland) · Vildagliptin, Vildagliptin Accord-Uk
- Greece · Dalmevin, Varbos
- Croatia · Agnis, Dalmevin
- Hungary · Agartha, Alikval
- Ireland · Vildagliptin Krka
- Iceland · Galvus, Jalra
- Italy · Vildagliptin Accord, Vildagliptin Aurobindo
- Liechtenstein · Galvus, Jalra
- Lithuania · Dalmevin, Glypvilo
- Latvia · Dalmevin, Glypvilo
- Malta · Alikval, Dalmevin
- Netherlands · Vilanov, Vildagliptine Accord
- Norway · Galvus, Jalra
- Portugal · Tutecvi, Vezagla
- Romania · Agartha, Dalmevin
- Sweden · Dalmevin, Kwikaton
- Slovenia · Glypvilo
- Slovakia · Anvildis, Dalmevin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/362cd06d-4850-4165-8a1f-393f7bbfbc18 GET /v1/drugs/362cd06d-4850-4165-8a1f-393f7bbfbc18?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "50 mg",
"packaging": "05909991729660 ¦ Rp ¦ 160068\n7 tabl.\n05909991729677 ¦ Rp ¦ 160069\n30 tabl.\n05909991729684 ¦ Rp ¦ 160070\n56 tabl.\n05909991729691 ¦ Rp ¦ 160071\n60 tabl.\n05909991729707 ¦ Rp ¦ 160072\n112 tabl.\n05909991729714 ¦ Rp ¦ 160073\n336 tabl. w blistrze (opak. zbiorcze)\n05909991729721 ¦ Rp ¦ 160074\n28 tabl.\n05909991563493 ¦ Rp ¦ 160075\n90 tabl.\n05909991563509 ¦ Rp ¦ 160076\n180 tabl.\n05909991563516 ¦ Rp ¦ 160077\n14 tabl.\n05909991563523 ¦ Rp ¦ 160078\n336 tabl. w blistrze",
"substance": "Vildagliptinum 50 mg",
"common_name": "Vildagliptinum",
"pl_product_id": "100449464",
"pozwolenie_nr": "28823",
"auth_procedure": "DCP",
"authorisation_validity": "2030-01-21"
}See everything about vildagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.